TUDOR INVESTMENT CORP ET AL - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 111 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$88,000
-40.9%
25,263
+114.7%
0.00%
-60.0%
Q2 2017$149,000
-71.4%
11,767
-76.3%
0.01%
-68.8%
Q1 2017$521,000
+33.6%
49,589
+16.9%
0.02%
+60.0%
Q4 2016$390,000
+146.8%
42,405
+216.5%
0.01%
+150.0%
Q3 2016$158,000
-79.2%
13,398
-49.5%
0.00%
-81.0%
Q4 2015$759,000
+44.0%
26,517
+43.1%
0.02%
+16.7%
Q3 2015$527,000
+4.6%
18,532
+32.1%
0.02%
+20.0%
Q2 2015$504,000
+89.5%
14,030
+207.0%
0.02%
+66.7%
Q1 2015$266,000
-49.3%
4,570
-63.3%
0.01%
-50.0%
Q4 2014$525,000
-39.5%
12,448
-44.4%
0.02%
-41.9%
Q3 2014$868,000
+57.8%
22,394
+27.1%
0.03%
+47.6%
Q2 2014$550,00017,6260.02%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2014
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders